Yesterday, Nov. 4, 2015, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $85.86 to $4,999,847.37.

Highlighted Stocks Traded by Insiders:

Northwest (NWBI) - FREE Research Report

Hunter Timothy M, who is Director at Northwest, bought 1,000 shares at $13.34 on Nov. 4, 2015. Following this transaction, the Director owned 5,700 shares meaning that the stake was boosted by 21.28% with the 1,000-share transaction.

The shares most recently traded at $13.43, up $0.09, or 0.67% since the insider transaction. Historical insider transactions for Northwest go as follows:

  • 4-Week # shares bought: 800
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 800
  • 12-Week # shares sold: 1,500
  • 24-Week # shares bought: 1,800
  • 24-Week # shares sold: 1,500

The average volume for Northwest has been 706,900 shares per day over the past 30 days. Northwest has a market cap of $1.3 billion and is part of the financial sector and banking industry. Shares are up 6.94% year-to-date as of the close of trading on Wednesday.

Northwest Bancshares, Inc. operates as a bank holding company for Northwest Savings Bank that offers various personal and business banking solutions in the United States. The company operates through two segments, Community Banking and Consumer Finance. The stock currently has a dividend yield of 4.19%. The company has a P/E ratio of 18.5. Currently, there are no analysts who rate Northwest a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NWBI - FREE

TheStreet Quant Ratings

rates Northwest as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Northwest Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

GenMark Diagnostics (GNMK) - FREE Research Report

Oboyle Kevin C, who is Director at GenMark Diagnostics, bought 4,500 shares at $6.71 on Nov. 4, 2015. Following this transaction, the Director owned 47,798 shares meaning that the stake was boosted by 10.39% with the 4,500-share transaction.

The shares most recently traded at $7.00, up $0.29, or 4.14% since the insider transaction. Historical insider transactions for GenMark Diagnostics go as follows:

  • 4-Week # shares bought: 9,000
  • 4-Week # shares sold: 14,245
  • 12-Week # shares bought: 9,000
  • 12-Week # shares sold: 46,215
  • 24-Week # shares bought: 9,000
  • 24-Week # shares sold: 60,014

The average volume for GenMark Diagnostics has been 350,100 shares per day over the past 30 days. GenMark Diagnostics has a market cap of $282.2 million and is part of the health care sector and health services industry. Shares are down 47.69% year-to-date as of the close of trading on Wednesday.

GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology in the United States. Currently, there are 5 analysts who rate GenMark Diagnostics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GNMK - FREE

TheStreet Quant Ratings

rates GenMark Diagnostics as a

sell

. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

GenMark Diagnostics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Flotek Industries (FTK) - FREE Research Report

Reiland John, who is Director at Flotek Industries, sold 4,380 shares at $19.21 on Nov. 4, 2015. Following this transaction, the Director owned 8,535 shares meaning that the stake was reduced by 33.91% with the 4,380-share transaction.

The shares most recently traded at $18.11, down $1.10, or 6.09% since the insider transaction. Historical insider transactions for Flotek Industries go as follows:

  • 4-Week # shares bought: 3,000
  • 4-Week # shares sold: 4,000
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 123,686

The average volume for Flotek Industries has been 1.2 million shares per day over the past 30 days. Flotek Industries has a market cap of $1.0 billion and is part of the basic materials sector and energy industry. Shares are down 0.8% year-to-date as of the close of trading on Wednesday.

Flotek Industries, Inc. develops and supplies oilfield products, services, and equipment to the oil, gas, and mining industries in the United States and internationally. The company has a P/E ratio of 240.2. Currently, there is 1 analyst who rates Flotek Industries a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on FTK - FREE

TheStreet Quant Ratings

rates Flotek Industries as a

hold

. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full

Flotek Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.